Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Lilly Stories

2013-10-09 08:26:52

Globally, more than 20,000 Lilly employees will help improve communities in 60 countries INDIANAPOLIS, Oct. 9, 2013 /PRNewswire/ -- Eli Lilly and Company's (NYSE: LLY) sixth Global Day of Service in Indianapolis will look a little different this year. Lilly employees will join thousands of other volunteers from local community and civic-based organizations in a city-wide initiative known as Indy DO Day. Together, this united army of volunteers will make Indianapolis a better place to live....

2013-10-01 08:31:20

16th annual scholarship program for individuals living with severe and persistent mental illness expands to include those living with major depressive disorder INDIANAPOLIS, Oct. 1, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that applications for the 2014-2015 school year are now available for the 16(th) annual Lilly Reintegration Scholarship. Since its inception, the program has directed more than four million dollars in tuition, books and laboratory fees...

2013-09-30 16:25:05

INDIANAPOLIS, Sept. 30, 2013 /PRNewswire/ -- WHAT: Eli Lilly and Company (NYSE:LLY) will host a meeting for the investment community, including major long-term investors, sell-side analysts, financial media and ratings agency representatives. WHEN: The meeting will take place Thursday, Oct. 3, 2013. The meeting will start at 8:30 a.m. (EDT) and last until approximately 12:30 p.m. (EDT). WHO: Company leaders will provide an in-depth update of its financial results, its...

2013-09-26 08:27:14

Improvements in several indicators of diabetes management, including perceptions about hyperglycaemia and weight, observed for investigational GLP-1 receptor agonist BARCELONA, Spain, Sept. 26, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive patient-reported health outcomes from a Phase III clinical trial of dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes....

2013-09-26 08:26:59

-- Additional Phase III Top-Line Results in Other Tumor Types Expected in 2014 -- INDIANAPOLIS, Sept. 26, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced top-line results from two global Phase III studies of ramucirumab (IMC-1121B), one in advanced gastric cancer and another in metastatic breast cancer. The RAINBOW trial, a global Phase III study of ramucirumab in combination with paclitaxel in patients with advanced gastric cancer, met its primary endpoint of...

2013-09-19 08:28:42

NEW YORK, Sept. 19, 2013 /PRNewswire/ -- Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation using Exosome Diagnostics proprietary EXO50 nucleic acid extraction kit. Under the agreement, Lilly will gain early access to Exosome Diagnostics technology to help identify key gene mutations and expression levels in blood that may be correlated with drug response and disease...

2013-09-17 08:31:18

Company to showcase late-stage pipeline, including efficacy, safety and patient-reported health outcomes data for investigational GLP-1 receptor agonist INDIANAPOLIS, Sept. 17, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that a total of 31 abstracts will be presented at the 49(th) European Association for the Study of Diabetes Annual Meeting in Barcelona, September 23-27. In seven presentations, Lilly will share Phase III data for dulaglutide, its investigational...

2013-09-12 23:20:36

Research shows that 9 out of 10 American youth give to charity Washington, D.C. (PRWEB) September 12, 2013 A first-of-its-kind study supported by the United Nations Foundation and conducted by the Women’s Philanthropy Institute at Indiana University Lilly Family School of Philanthropy, reports that nearly 9 out of 10 American youth between the ages eight and 19 give money to organizations dedicated to charitable causes. The research further reveals the important role parents play in...

2013-09-11 23:24:38

Kristine Lilly and Coerver Coaching Partner to Create eBook; Share Soccer and Life Lessons with Female Soccer Players, Parents, and Coaches (PRWEB) September 11, 2013 Kristine Lilly, two time FIFA World Cup champion and two time Olympic gold medalist, and Coerver® Coaching, the world’s number one soccer skills teaching method, have released the new eBook, “Girls Soccer: Dream, Believe, Achieve”. “Girls Soccer: Dream, Believe, Achieve” was created to raise awareness for...

2013-09-10 16:26:17

-- Robust Top-line and Earnings Growth at Tommy Bahama and Lilly Pulitzer -- ATLANTA, Sept. 10, 2013 /PRNewswire/ -- Oxford Industries, Inc. (NYSE: OXM) today announced financial results for its fiscal 2013 second quarter, which ended August 3, 2013. For the quarter, consolidated net sales increased 14% to $235.0 million compared to $206.9 million in the second quarter of fiscal 2012, which ended July 28, 2012. On an adjusted basis, earnings per share rose 55% to $1.01 compared to...